Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-27

Clinical Trial Update: Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial tested three doses of tiotropium versus placebo in adolescents (12-17) with moderate asthma to evaluate efficacy and safety. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2012-06-27